REPOCEUTICALS A/S: Financial statements 2022
CVR: 36494433
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
REPOCEUTICALS A/S (CVR 36494433) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 0 and a net result of DKK -3,828,782 compared with DKK -4,402,347 the year before. Equity in the 2022 report amounted to DKK 8,300,357. The solvency ratio was 87.5%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -3,828,782
- Equity
- DKK 8,300,357
- Total Assets
- DKK 9,490,657
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 0 | 0 | -3.8M | 8.3M | - |
| 2021 | 0 | 0 | -4.4M | 12M | - |
| 2020 | 0 | 0 | -859K | 5.2M | - |
| 2019 | 0 | 0 | -523K | 6M | - |
| 2018 | 0 | 0 | -383K | -356K | - |
Official annual report
Keep an eye on REPOCEUTICALS A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
REPOCEUTICALS A/S has published its annual report for 2021. Revenue came to DKK 0, and the net result was DKK -4,402,347.
About REPOCEUTICALS A/S
REPOCEUTICALS A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2015. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named REPOCEUTICALS ApS. The management consists of Torsten Bjørn. The board consists of Henrik Bulskov (chair), Charlotte Pahl and Christian Vinding Thomsen. The company's owners include NIELS ERIK JESPERSEN HOLDING ApS, Beier Holding ApS and DMZ HOLDING ApS. The company has 2 employees (2026). In 2025, the company reported revenue of DKK 88,000,000 and a net result of DKK -6,228,938,000 compared with DKK -6,274,548 the year before. Equity in the 2025 report amounted to DKK 6,245,088,000.